Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 4/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.43 |
| ▸ | MAPT | P10636 | 4/20 | 0.43 |
| ▸ | HPGD | P15428 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 4/20 | 0.39 |
| ▸ | CA1 | P00915 | 3/20 | 0.39 |
| ▸ | EGFR | P00533 | 2/20 | 0.38 |
| ▸ | FYN | P06241 | 2/20 | 0.38 |
| ▸ | MMP9 | P14780 | 2/20 | 0.38 |
| ▸ | RECQL | P46063 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9454007 | 0.83 | TSHR (0.54) | TSHRALDH1A1LMNAALOX15HSD17B10 | |
| SCHEMBL70074 | 0.82 | TSHR (0.32) | TSHRALDH1A1LMNACYP3A4CA2 | |
| SCHEMBL10611186 | 0.80 | ALDH1A1 (0.58) | TSHRALDH1A1LMNAALOX15HSD17B10 | |
| SCHEMBL1008486 | 0.79 | TP53 (0.64) | TSHRALDH1A1LMNAALOX15HSD17B10 | |
| SCHEMBL70607 | 0.78 | CYP3A4 (0.50) | TSHRALDH1A1LMNAALOX15HSD17B10 | |
| SCHEMBL1125159 | 0.77 | TSHR (0.48) | TSHRALDH1A1LMNAALOX15HSD17B10 | |
| SCHEMBL1931496 | 0.77 | — | — | |
| SCHEMBL30020007 | 0.77 | — | — | |
| SCHEMBL69881 | 0.76 | — | — | |
| SCHEMBL28061476 | 0.76 | TSHR (0.64) | TSHRALDH1A1LMNAALOX15HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111960932-B | Dichlororesorcinol compound and preparation method and medical application thereof | 沈阳药科大学 | 2022-11-08 | — | — | CN | claimed |
| CN-111960932-A | Dichlororesorcinol compound and preparation method and medical application thereof | 沈阳药科大学 | 2020-11-20 | — | — | CN | claimed |
| CN-103736239-A | Fire extinguishing composition containing aldoketones compound | XI AN JIAN RUI SAFETY EMERGENCY EQUIPMENT LTD LIABILITY COMPANY | 2014-04-23 | — | — | CN | claimed |
| CN-103736237-A | Fire extinguishing composition containing hydroxyketone compound and derivatives of hydroxyketone compound | XI AN JIAN RUI SAFETY EMERGENCY EQUIPMENT LTD LIABILITY COMPANY | 2014-04-23 | — | — | CN | claimed |
| EP-1161414-B1 | CYANATE ESTERS HAVING FLAME RESISTANT PROPERTIES | VANTICO AG (CH) | 2003-10-01 | — | — | EP | claimed |
| US-20020055648-A1 | Cyanate esters having flame resistant properties | JPMORGAN CHASE BANK, N.A. | 2002-05-09 | — | — | US | claimed |
| EP-1161414-A1 | CYANATE ESTERS HAVING FLAME RESISTANT PROPERTIES | Vantico AG (CH) | 2001-12-12 | — | — | EP | claimed |
| US-6242638-B1 | FIREPROOFING USING CURED MIXTURES | VANTICO INC. | 2001-06-05 | — | — | US | claimed |
| WO-2000055123-A1 | CYANATE ESTERS HAVING FLAME RESISTANT PROPERTIES | VANTICO AG (CH) | 2000-09-21 | — | — | WO | claimed |
| US-20240167922-A1 | TRANSPARENTIZING REAGENT AND TRANSPARENTIZING METHOD | KYOTO UNIVERSITY (JP) | 2024-05-23 | — | — | US | disclosed |
| EP-4306927-A1 | TRANSPARENTIZING REAGENT AND TRANSPARENTIZING METHOD | Kyoto University (JP) | 2024-01-17 | — | — | EP | disclosed |
| CN-111960932-B | Dichlororesorcinol compound and preparation method and medical application thereof | 沈阳药科大学 | 2022-11-08 | — | — | CN | disclosed |
| CN-111960932-B | Dichlororesorcinol compound and preparation method and medical application thereof | 沈阳药科大学 | 2022-11-08 | — | — | CN | disclosed |
| CN-111960932-B | Dichlororesorcinol compound and preparation method and medical application thereof | 沈阳药科大学 | 2022-11-08 | — | — | CN | disclosed |
| WO-2000055123-A1 | CYANATE ESTERS HAVING FLAME RESISTANT PROPERTIES | VANTICO AG (CH) | 2000-09-21 | — | — | WO | disclosed |
| US-5115074-A | Condensation of carboxylic aldehyde and phenol as a novolak for heat, chemical, water resistant polymers | TEIJIN LIMITED (JP) | 1992-05-19 | — | — | US | disclosed |
| EP-0431891-A1 | Epoxy compounds, production processes thereof and cured product of the epoxy compound | TEIJIN LIMITED (JP) | 1991-06-12 | — | — | EP | disclosed |
| EP-0387554-A2 | Liquid epoxy polymer composition and use thereof | International Business Machines Corporation (US) | 1990-09-19 | — | — | EP | disclosed |
| EP-0375980-A2 | Epoxy composition of increased thermal conductivity and use thereof | International Business Machines Corporation (US) | 1990-07-04 | — | — | EP | disclosed |
| US-4416950-A | COATING WITH A DICYCLOPENTENYL ACRYLATE MONOMER AND POLYMERIZING | ANDREWS PAPER & CHEMICAL CO. (US) | 1983-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020055648-A1 | Cyanate esters having flame resistant properties | PCCA, FABP4, MCCC2 | TSHR 4633/4885ALDH1A1 1536/4885LMNA 112/4885 |
| US-20240167922-A1 | TRANSPARENTIZING REAGENT AND TRANSPARENTIZING METHOD | TST, TTR, ALB | TSHR 2764/4885ALDH1A1 3942/4885LMNA 1853/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.